$EXPO Cashflow Statement | Understand Stock

$EXPO

$76.45 -$1.21 (1.56%) Close

Financial Statements

In millions of USD, except per-share amounts

	FY2025 12 months to Jan 2, 2026	FY2024 12 months to Jan 3, 2025	FY2023 12 months to Dec 29, 2023	FY2022 12 months to Dec 30, 2022	FY2021 12 months to Dec 31, 2021
Cash flows from operating activities:
Net income
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization of property, equipment and leasehold improvements
Amortization of premiums and accretion of discounts on short-term investments
Provision for contract losses and doubtful accounts
Stock-based compensation
Deferred income tax provision
Changes in operating assets and liabilities:
Accounts receivable
Prepaid expenses and other current assets
Change in operating leases
Accounts payable and accrued liabilities
Accrued payroll and employee benefits
Deferred revenues

Net cash provided by operating activities
Cash flows from investing activities:
Capital expenditures
Purchase of short-term investments
Maturity of short-term investments
Net cash used in investing activities

Cash flows from financing activities:
Payroll taxes for restricted stock units
Repurchase of common stock
Exercise of stock-based payment awards
Dividends and dividend equivalent rights
Net cash used in financing activities
Effect of foreign currency exchange rates on cash and cash equivalents
Net change in cash and cash equivalents
Cash and cash equivalents at beginning of year
Cash and cash equivalents at end of year

Comments